24 February 2025
CQS New City High Yield Fund Limited(“NCYF” or the “Company”) Monthly Factsheet as at 31 January 2025 The Company’s Fact Sheet as at 31…
20 February 2025
Notice to ASX/LSE Notices of 2025 annual general meetings 20 February 2025 Rio Tinto is today issuing the notices for the 2025 annual general…
Nucala (mepolizumab) application for COPD accepted for review in China GSK plc (LSE/NYSE: GSK) today announced that the China National Medical Products Administration has accepted for review the new…
RESULTS FOR THE FULL YEAR “In 2024 we continued to Help Britain Prosper, delivering for our customers, shareholders and wider stakeholders. We successfully completed…
19 February 2025
Statement re Possible Offer from Kohlberg Kravis Roberts & Co. Partners L.L.P. (“KKR”) The Board of Assura plc (“Assura” or the “Company”) notes the…
18 February 2025
BHP Group Limited Financial results for the half year ended 31 December 2024 18 February 2025 Operational excellence underpins strong returns and investment in…
Euronext publishes Q4 and full year 2024 results Euronext delivered double-digit revenue growth in 2024 thanks to its diversified revenue profile and confirms the…
17 February 2025
Penmenvy, GSK’s 5-in-1 meningococcal vaccine, approved by US FDA to help protect against MenABCWY GSK plc (LSE/NYSE: GSK) today announced that the US Food and…